MEDINA PADILLA, Miguel,DOMÍNGUEZ CORREA, Juan Manuel,DE CRISTOBAL BLANCO, Javier,FUERTES HUERTA, Ana,SÁNCHEZ-QUESADA, Jorge,LÓPEZ OGALLA, Javier,HERRERO SANTOS, Susana,PÉREZ DE LA CRUZ MORENO, María Á
申请号：
AU2017248556
公开号：
AU2017248556A1
申请日:
2017.10.20
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2017248556A120171109.pdf#####ABSTRACT The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.
